BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 28332361)

  • 1. Occult HBV among Anti-HBc Alone: Mutation Analysis of an HBV Surface Gene and Pre-S Gene.
    Kim MH; Kang SY; Lee WI
    Yonsei Med J; 2017 May; 58(3):557-563. PubMed ID: 28332361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High levels of serum hepatitis B virus DNA in patients with 'anti-HBc alone': role of HBsAg mutants.
    Launay O; Masurel J; Servant-Delmas A; Basse-Guérineau AL; Méritet JF; Laperche S; Sogni P; Rosenberg AR
    J Viral Hepat; 2011 Oct; 18(10):721-9. PubMed ID: 21914087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of occult hepatitis B virus infection among HIV positive patients in Cameroon.
    Gachara G; Magoro T; Mavhandu L; Lum E; Kimbi HK; Ndip RN; Bessong PO
    AIDS Res Ther; 2017 Mar; 14(1):11. PubMed ID: 28270215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B virus genotypes and hepatitis B surface antigen mutations in family contacts of hepatitis B virus infected patients with occult hepatitis B virus infection.
    Kumar GT; Kazim SN; Kumar M; Hissar S; Chauhan R; Basir SF; Sarin SK
    J Gastroenterol Hepatol; 2009 Apr; 24(4):588-98. PubMed ID: 19207682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevalence of "anti-HBc alone" and HBV DNA detection among anti-HBc alone in Korea.
    Kang SY; Kim MH; Lee WI
    J Med Virol; 2010 Sep; 82(9):1508-14. PubMed ID: 20648604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology, risk factors, and molecular characterization of occult hepatitis B infection among anti-hepatitis B core antigen alone subjects.
    Azarkar Z; Ziaee M; Ebrahimzadeh A; Sharifzadeh G; Javanmard D
    J Med Virol; 2019 Apr; 91(4):615-622. PubMed ID: 30345529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presence of anti-HBc is associated to high rates of HBV resolved infection and low threshold for Occult HBV Infection in HIV patients with negative HBsAg in Chile.
    Vargas JI; Jensen D; Sarmiento V; Peirano F; Acuña P; Fuster F; Soto S; Ahumada R; Huilcaman M; Bruna M; Jensen W; Fuster F
    J Med Virol; 2016 Apr; 88(4):639-46. PubMed ID: 26381185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Epidemiological and clinical features of occult hepatitis B in HIV infection without antiretroviral treatment].
    Zhang RF; Liu L; Zheng YF; Shen YZ; Chen J; Gu SM; Wang JR; Lu HZ
    Zhonghua Gan Zang Bing Za Zhi; 2013 Mar; 21(3):189-91. PubMed ID: 23967739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virological characteristics of occult hepatitis B virus in a North American cohort of human immunodeficiency virus type 1-positive patients on dual active anti-HBV/HIV therapy.
    Coffin CS; Mulrooney-Cousins PM; Osiowy C; van der Meer F; Nishikawa S; Michalak TI; van Marle G; Gill MJ
    J Clin Virol; 2014 Aug; 60(4):347-53. PubMed ID: 24881491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of occult hepatitis B virus infection in anti-hbc positive patients from a liver clinic.
    Martinez MC; Kok CC; Baleriola C; Robertson P; Rawlinson WD
    PLoS One; 2015; 10(3):e0117275. PubMed ID: 25763579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotype, phylogenetic analysis, and transmission pattern of occult hepatitis B virus (HBV) infection in families of asymptomatic HBsAg carriers.
    Datta S; Banerjee A; Chandra PK; Chowdhury A; Chakravarty R
    J Med Virol; 2006 Jan; 78(1):53-9. PubMed ID: 16299727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low rate of occult hepatitis B virus infection among anti-HBc positive blood donors living in a low prevalence region in Brazil.
    Silva CM; Costi C; Costa C; Michelon C; Oravec R; Ramos AB; Niel C; Rossetti ML
    J Infect; 2005 Jul; 51(1):24-9. PubMed ID: 15979486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serological pattern of anti-HBc alone infers occult hepatitis B virus infection in high-risk individuals in Iran.
    Ramezani A; Banifazl M; Eslamifar A; Aghakhani A
    J Infect Dev Ctries; 2010 Oct; 4(10):658-61. PubMed ID: 21045360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occult hepatitis B virus infection in hemodialysis patients in Recife, State of Pernambuco, Brazil.
    Albuquerque AC; Coelho MR; Lemos MF; Moreira RC
    Rev Soc Bras Med Trop; 2012 Oct; 45(5):558-62. PubMed ID: 23152336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T- and B-cell responses and previous exposure to hepatitis B virus in 'anti-HBc alone' patients.
    Wang Q; Sachse P; Semmo M; Lokhande M; Montani M; Dufour JF; Zoulim F; Klenerman P; Semmo N
    J Viral Hepat; 2015 Dec; 22(12):1068-78. PubMed ID: 26075501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular analysis of the hepatitis B virus presurface and surface gene in patients from eastern China with occult hepatitis B.
    Huang X; Qin Y; Li W; Shi Q; Xue Y; Li J; Liu C; Hollinger FB; Shen Q
    J Med Virol; 2013 Jun; 85(6):979-86. PubMed ID: 23588723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occult hepatitis B virus infection in Korean patients with isolated anti-HBc.
    Kang SY; Kim MH; Lee WI
    Arch Virol; 2014 Feb; 159(2):227-33. PubMed ID: 23933720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors and kinetics of occult hepatitis B virus infection in HIV-infected persons.
    Nebbia G; Garcia-Diaz A; Ayliffe U; Smith C; Dervisevic S; Johnson M; Gilson R; Tedder R; Geretti AM
    J Med Virol; 2007 Oct; 79(10):1464-71. PubMed ID: 17705185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of anti-HBc screening of blood donors and its association with occult hepatitis B virus infection: Implications for blood transfusion.
    Asim M; Ali R; Khan LA; Husain SA; Singla R; Kar P
    Indian J Med Res; 2010 Sep; 132():312-7. PubMed ID: 20847378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical course and core variability in HBV infected patients without detectable anti-HBc antibodies.
    Anastasiou OE; Widera M; Verheyen J; Korth J; Gerken G; Helfritz FA; Canbay A; Wedemeyer H; Ciesek S
    J Clin Virol; 2017 Aug; 93():46-52. PubMed ID: 28622640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.